{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T17:20:41Z","timestamp":1792516841791,"version":"4.5.0"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,4]],"date-time":"2025-08-04T00:00:00Z","timestamp":1754265600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,8,4]],"date-time":"2025-08-04T00:00:00Z","timestamp":1754265600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Nephrol"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Introduction<\/jats:title>\n            <jats:p>Chronic kidney disease (CKD) is a well-documented risk factor for major adverse cardiac events and bleeding events. The optimal antiplatelet strategy for patients with CKD remains unclear, especially patients with glomerular filtration rate (GFR)\u2009&lt;\u200930\u00a0ml\/min. We aim to compare clinical outcomes of patients with acute coronary syndrome (ACS) and CKD treated with ticagrelor or prasugrel vs. clopidogrel.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>Patients were collected from the acute coronary syndrome Israeli survey (ACSIS). Patients were divided into 2 groups: ST-segment myocardial infarction (STEMI) and non-STEMI. Each group was further divided based on the GFR value (&lt;30\u00a0ml\/min or\u2009\u2265\u200930\u00a0ml\/min). Mortality, bleeding, repeat revascularization, and re-hospitalization at 30-day and 1-year were evaluated.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>A total of 5,442 patients were included in the final analysis. There were no significant differences regarding baseline characteristics between both groups of ACS patients. In patients with STEMI and GFR\u2009&lt;\u200930\u00a0ml\/min, re-hospitalization (32% vs. 29 % p\u2009=\u20091.0), bleeding (2.7% vs 2.3% p\u2009=\u20090.9), and death rates (8.1 % vs 2.3% p\u2009=\u20090.5) did not differ between the two different treatment strategies at 30-day follow-up. The mortality rate in 1-year was lower among STEMI patients treated with the ticagrelor or prasugrel as compared with clopidogrel (33% vs 11% p\u2009=\u20090.04).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>In patients with ACS and CKD, rehospitalization, bleeding and mortality rates were similar in30 days in patients treated with ticagrelor\/prasugrel versus clopidogrel. Nevertheless, in patients presenting with STEMI and GFR\u2009&lt;\u200930\u00a0ml\/min, treatment with ticagrelor\/prasugrel was correlated with a lower 1-year mortality rate as compared with clopidogrel treatment with no increase in bleeding rates.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/s12882-025-04227-8","type":"journal-article","created":{"date-parts":[[2025,8,4]],"date-time":"2025-08-04T19:30:29Z","timestamp":1754335829000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Optimal antiplatelet therapy in patients with acute coronary syndrome and chronic kidney disease: for the Jerusalem platelets thrombosis and intervention in cardiology (JUPITER-11) study group"],"prefix":"10.1186","volume":"26","author":[{"given":"Perel","family":"Nimrod","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marmor","family":"David","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taha","family":"Louay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tabi","family":"Meir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Itshak","family":"Amsalem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafi","family":"Hitter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomer","family":"Maller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nir","family":"Levy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lior","family":"Lupu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hezzy","family":"Shmueli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharon","family":"Bruoha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tal","family":"Ovdat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Glikson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elad","family":"Asher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,4]]},"reference":[{"issue":"13","key":"4227_CR1","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1056\/NEJMOA041365","volume":"351","author":"NS Anavekar","year":"2004","unstructured":"Anavekar NS, McMurray JJV, Velazquez EJ, et al. Relation between renal dysfunction and cardiovascular outcomes after myocardial infarction. N Engl J Med. 2004;351(13):1285\u201395. https:\/\/doi.org\/10.1056\/NEJMOA041365","journal-title":"N Engl J Med"},{"issue":"8","key":"4227_CR2","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1161\/01.CIR.0000027560.41358.B3","volume":"106","author":"J Al Suwaidi","year":"2002","unstructured":"Al Suwaidi J, Reddan DN, Williams K, et al. Prognostic implications of abnormalities in renal function in patients with acute coronary syndromes. Circulation. 2002;106(8):974\u201380. https:\/\/doi.org\/10.1161\/01.CIR.0000027560.41358.B3","journal-title":"Circulation"},{"issue":"17","key":"4227_CR3","doi-asserted-by":"publisher","first-page":"E1371","DOI":"10.4244\/EIJ-D-21-00904","volume":"17","author":"DJ Angiolillo","year":"2022","unstructured":"Angiolillo DJ, Galli M, Collet JP, Kastrati A, O\u2019Donoghue ML Antiplatelet therapy after percutaneous coronary intervention. EuroIntervention. 2022;17(17):E1371\u2013E1396. https:\/\/doi.org\/10.4244\/EIJ-D-21-00904","journal-title":"EuroIntervention"},{"issue":"17","key":"4227_CR4","doi-asserted-by":"publisher","first-page":"1867","DOI":"10.1016\/J.JCIN.2021.07.026","volume":"14","author":"O De Filippo","year":"2021","unstructured":"De Filippo O, D\u2019Ascenzo F, De Ferrari GM Antiplatelet therapy in acute coronary syndrome patients with impaired renal function: the destination matters! JACC Cardiovasc Interv. 2021;14(17):1867\u201369. https:\/\/doi.org\/10.1016\/J.JCIN.2021.07.026","journal-title":"JACC Cardiovasc Interv"},{"issue":"20","key":"4227_CR5","doi-asserted-by":"publisher","first-page":"2001","DOI":"10.1056\/NEJMOA0706482","volume":"357","author":"SD Wiviott","year":"2007","unstructured":"Wiviott SD, Braunwald E, McCabe CH, et al. Prasugrel versus clopidogrel in patients with acute coronary syndromes. N Engl J Med. 2007;357(20):2001\u201315. https:\/\/doi.org\/10.1056\/NEJMOA0706482","journal-title":"N Engl J Med"},{"issue":"11","key":"4227_CR6","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1056\/NEJMOA0904327","volume":"361","author":"L Wallentin","year":"2009","unstructured":"Wallentin L, Becker RC, Budaj A, et al. Ticagrelor versus clopidogrel in patients with acute coronary syndromes. N Engl J Med. 2009;361(11):1045\u201357. https:\/\/doi.org\/10.1056\/NEJMOA0904327","journal-title":"N Engl J Med"},{"issue":"11","key":"4227_CR7","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1161\/CIRCULATIONAHA.109.933796","volume":"122","author":"S James","year":"2010","unstructured":"James S, Budaj A, Aylward P, et al. Ticagrelor versus clopidogrel in acute coronary syndromes in relation to renal function: results from the platelet inhibition and patient outcomes (PLATO) trial. Circulation. 2010;122(11):1056\u201367. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.109.933796","journal-title":"Circulation"},{"issue":"16","key":"4227_CR8","doi-asserted-by":"publisher","first-page":"1524","DOI":"10.1056\/NEJMOA1908973","volume":"381","author":"S Sch\u00fcpke","year":"2019","unstructured":"Sch\u00fcpke S, Neumann FJ, Menichelli M, et al. Ticagrelor or prasugrel in patients with acute coronary syndromes. N Engl J Med. 2019;381(16):1524\u201334. https:\/\/doi.org\/10.1056\/NEJMOA1908973","journal-title":"N Engl J Med"},{"issue":"17","key":"4227_CR9","doi-asserted-by":"publisher","first-page":"1857","DOI":"10.1016\/J.JCIN.2021.06.028","volume":"14","author":"J W\u00f6hrle","year":"2021","unstructured":"W\u00f6hrle J, Seeger J, Lahu S, et al. Ticagrelor or prasugrel in patients with acute coronary syndrome in relation to estimated glomerular filtration rate. JACC Cardiovasc Interv. 2021;14(17):1857\u201366. https:\/\/doi.org\/10.1016\/J.JCIN.2021.06.028","journal-title":"JACC Cardiovasc Interv"},{"issue":"6","key":"4227_CR10","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1016\/J.REC.2021.05.002","volume":"74","author":"JP Collet","year":"2020","unstructured":"Collet JP, Thiele H, Barbato E, et al. 2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. Rev Esp Cardiol (Engl Ed). 2021;74(6):544. https:\/\/doi.org\/10.1016\/J.REC.2021.05.002","journal-title":"Rev Esp Cardiol (Engl Ed)"},{"issue":"2","key":"4227_CR11","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1093\/EURHEARTJ\/EHX393","volume":"39","author":"B Ibanez","year":"2017","unstructured":"Ibanez B, James S, Agewall S, et al. 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: the Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the european society of cardiology (ESC). Eur Heart J. 2018;39(2):119\u201377. https:\/\/doi.org\/10.1093\/EURHEARTJ\/EHX393","journal-title":"Eur Heart J"},{"issue":"4","key":"4227_CR12","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1002\/CLC.23781","volume":"45","author":"L Lupu","year":"2022","unstructured":"Lupu L, Taha L, Banai A, et al. Immediate and early percutaneous coronary intervention in very high-risk and high-risk non-ST segment elevation myocardial infarction patients. Clin Cardiol. 2022;45(4):359\u201369. https:\/\/doi.org\/10.1002\/CLC.23781","journal-title":"Clin Cardiol"},{"issue":"23","key":"4227_CR13","doi-asserted-by":"publisher","first-page":"2736","DOI":"10.1161\/CIRCULATIONAHA.110.009449\/FORMAT\/EPUB","volume":"123","author":"R Mehran","year":"2011","unstructured":"Mehran R, V. RS, Bhatt DL, et al. Standardized bleeding definitions for cardiovascular clinical trials: a consensus report from the bleeding academic research consortium. Circulation. 2011;123(23):2736\u201347. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.110.009449\/FORMAT\/EPUB","journal-title":"Circulation"},{"issue":"16","key":"4227_CR14","doi-asserted-by":"publisher","first-page":"2020","DOI":"10.1161\/CIR.0B013E31826E1058\/FORMAT\/EPUB","volume":"126","author":"K Thygesen","year":"2012","unstructured":"Thygesen K, Alpert JS, Jaffe AS, et al. Third universal definition of myocardial infarction. Circulation. 2012;126(16):2020\u201335. https:\/\/doi.org\/10.1161\/CIR.0B013E31826E1058\/FORMAT\/EPUB","journal-title":"Circulation"},{"issue":"7","key":"4227_CR15","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1016\/S0735-1097(02)01745-X","volume":"39","author":"PJM Best","year":"2002","unstructured":"Best PJM, Lennon R, Ting HH, et al. The impact of renal insufficiency on clinical outcomes in patients undergoing percutaneous coronary interventions. J Am Coll Cardiol. 2002;39(7):1113\u201319. https:\/\/doi.org\/10.1016\/S0735-1097(02)01745-X","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"4227_CR16","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/J.AMJMED.2005.08.057","volume":"119","author":"JH Han","year":"2006","unstructured":"Han JH, Chandra A, Mulgund J, et al. Chronic kidney disease in patients with non-ST-segment elevation acute coronary syndromes. Am J Med. 2006;119(3):248\u201354. https:\/\/doi.org\/10.1016\/J.AMJMED.2005.08.057","journal-title":"Am J Med"},{"issue":"1","key":"4227_CR17","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1111\/J.1365-2796.2009.02204.X","volume":"268","author":"K Szummer","year":"2010","unstructured":"Szummer K, Lundman P, Jacobson SH, et al. Relation between renal function, presentation, use of therapies and in-hospital complications in acute coronary syndrome: data from the SWEDEHEART register. J Intern Med. 2010;268(1):40\u201349. https:\/\/doi.org\/10.1111\/J.1365-2796.2009.02204.X","journal-title":"J Intern Med"},{"issue":"15","key":"4227_CR18","doi-asserted-by":"publisher","first-page":"1582","DOI":"10.1161\/CIRCULATIONAHA.118.032078","volume":"138","author":"L Bonello","year":"2018","unstructured":"Bonello L, Angiolillo DJ, Aradi D, Sibbing D. P2Y12-ADP receptor blockade in chronic kidney disease patients with acute coronary syndromes. Circulation. 2018;138(15):1582\u201396. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.118.032078","journal-title":"Circulation"},{"issue":"19","key":"4227_CR19","doi-asserted-by":"publisher","first-page":"1575","DOI":"10.1136\/HEARTJNL-2017-312436","volume":"104","author":"R Edfors","year":"2018","unstructured":"Edfors R, Sahl\u00e9n A, Szummer K, et al. Outcomes in patients treated with ticagrelor versus clopidogrel after acute myocardial infarction stratified by renal function. Heart. 2018;104(19):1575\u201382. https:\/\/doi.org\/10.1136\/HEARTJNL-2017-312436","journal-title":"Heart"},{"issue":"14","key":"4227_CR20","doi-asserted-by":"publisher","first-page":"1873","DOI":"10.1161\/CIRCULATIONAHA.108.828541","volume":"119","author":"S Subherwal","year":"2009","unstructured":"Subherwal S, Bach RG, Chen AY, et al. Baseline risk of major bleeding in non-ST-segment-elevation myocardial infarction: the CRUSADE (can rapid risk stratification of unstable angina patients suppress adverse outcomes with early implementation of the ACC\/AHA guidelines) bleeding Score. Circulation. 2009;119(14):1873\u201382. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.108.828541","journal-title":"Circulation"},{"issue":"23","key":"4227_CR21","doi-asserted-by":"publisher","first-page":"2556","DOI":"10.1016\/J.JACC.2009.09.076","volume":"55","author":"R Mehran","year":"2010","unstructured":"Mehran R, Pocock SJ, Nikolsky E, et al. A risk score to predict bleeding in patients with acute coronary syndromes. J Am Coll Cardiol. 2010;55(23):2556\u201366. https:\/\/doi.org\/10.1016\/J.JACC.2009.09.076","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"4227_CR22","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/J.AMJMED.2010.07.023","volume":"124","author":"DD McManus","year":"2011","unstructured":"McManus DD, Gore J, Yarzebski J, Spencer F, Lessard D, Goldberg RJ Recent trends in the incidence, treatment, and outcomes of patients with STEMI and NSTEMI. Am J Med. 2011;124(1):40\u201347. https:\/\/doi.org\/10.1016\/J.AMJMED.2010.07.023","journal-title":"Am J Med"},{"issue":"6","key":"4227_CR23","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1016\/J.JCIN.2011.02.011","volume":"4","author":"R Mehran","year":"2011","unstructured":"Mehran R, Pocock S, Nikolsky E, et al. Impact of bleeding on mortality after percutaneous coronary intervention results from a patient-level pooled analysis of the REPLACE-2 (randomized evaluation of PCI linking angiomax to reduced clinical events), ACUITY (acute catheterization and urgent intervention triage strategy), and HORIZONS-AMI (harmonizing outcomes with revascularization and stents in acute myocardial infarction) trials. JACC Cardiovasc Interv. 2011;4(6):654\u201364. https:\/\/doi.org\/10.1016\/J.JCIN.2011.02.011","journal-title":"JACC Cardiovasc Interv"},{"issue":"9","key":"4227_CR24","doi-asserted-by":"publisher","first-page":"2825","DOI":"10.1681\/ASN.2015050535\/-\/DCSUPPLEMENTAL","volume":"27","author":"AO Molnar","year":"2016","unstructured":"Molnar AO, Bota SE, Garg AX, et al. The risk of major hemorrhage with CKD. Journal of the American Society of Nephrology. 2016;27(9):2825\u201332. https:\/\/doi.org\/10.1681\/ASN.2015050535\/-\/DCSUPPLEMENTAL","journal-title":"Journal of the American Society of Nephrology"},{"issue":"1","key":"4227_CR25","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1093\/EHJCVP\/PVZ048","volume":"6","author":"O De Filippo","year":"2020","unstructured":"De Filippo O, D\u2019Ascenzo F, Raposeiras-Roubin S, et al. P2Y12 inhibitors in acute coronary syndrome patients with renal dysfunction: an analysis from the RENAMI and bleemacs projects. Eur Heart J Cardiovasc Pharmacother. 2020;6(1):31\u201342. https:\/\/doi.org\/10.1093\/EHJCVP\/PVZ048","journal-title":"Eur Heart J Cardiovasc Pharmacother"},{"key":"4227_CR26","doi-asserted-by":"publisher","first-page":"707722","DOI":"10.3389\/FCVM.2021.707722","volume":"8","author":"JW Roh","year":"2021","unstructured":"Roh JW, Lee SJ, Kim BK, et al. Ticagrelor vs. clopidogrel in acute coronary syndrome patients with chronic kidney disease after New-generation drug-eluting stent implantation. Front Cardiovasc Med. 2021;8:707722. https:\/\/doi.org\/10.3389\/FCVM.2021.707722","journal-title":"Front Cardiovasc Med"}],"container-title":["BMC Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-025-04227-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12882-025-04227-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-025-04227-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,5]],"date-time":"2025-08-05T13:04:31Z","timestamp":1754399071000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcnephrol.biomedcentral.com\/articles\/10.1186\/s12882-025-04227-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,4]]},"references-count":26,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4227"],"URL":"https:\/\/doi.org\/10.1186\/s12882-025-04227-8","relation":{},"ISSN":["1471-2369"],"issn-type":[{"value":"1471-2369","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,4]]},"assertion":[{"value":"4 January 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declaration"}},{"value":"Ethics approval and consent to participate-Informed consent is obtained from all participants. The Israeli Center for Cardiovascular Research (ICCR) and the ACS Israeli Surveys (ACSIS) review board (IRB) of all the participating hospitals approved the survey, which was performed in accordance with the Helsinki Declaration.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"429"}}